Umedica Laboratories Private Limited - Company Profile

It is a pharma private limited company based in Pardi, Gujarat, India, established in 1982.
1982 Pardi, Gujarat, India Active
Last Updated:
Access Report
About Umedica Laboratories Private Limited

Umedica Laboratories Private Limited, a active private limited company, was established on 05 January 1982 in Pardi, Gujarat, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24231GJ1982PTC141202. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹17.50 Cr and a paid-up capital of ₹3.60 Cr.

Formerly known as Umedica Laboratories Limited. It upholds a compliant status. Employing 869 professional, Its leadership includes Manish Umed Doshi (Managing Director), Rupesh Suryakant Kamdar (Director), Vandana Manish Doshi (Director). Past directors included Induben Umed Doshi, Manish Umed Doshi, Rupesh Suryakant Kamdar. It holds ₹531.86 Cr open charges and ₹188.81 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2024. It is based at P. No-221,222/1, Gidc, Vapi, Pardi, Gujarat, 396191.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24231GJ1982PTC141202

  • Registration Number

    141202

  • Incorporation Date

    05 January 1982

  • Authorized Capital

    ₹17.50 Cr

  • Paid-Up Capital

    ₹3.60 Cr

  • ROC Code

    Roc Ahmedabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 17.50 Cr
  • Paid Up Capital ₹ 3.60 Cr
  • Company Age 44 Year, 4 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 531.86 Cr
  • Satisfied Charges ₹ 188.81 Cr
  • Revenue Growth **** -1.46%
  • Profit Growth **** 148.35%
  • Ebitda **** 42.49%
  • Net Worth 6.66%
  • Total Assets -1.53%
Company report

Umedica Laboratories Private Limited

Company Report FY 2026-2027

Comprehensive Company Insights

Explore comprehensive insights into Umedica Laboratories Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Umedica Laboratories Private Limited?
Current Directors
Name Designation Appointment Date Status
Manish Umed Doshi Managing Director 05 Jan 1982 Current
Rupesh Suryakant Kamdar Director 02 Aug 2018 Current
Vandana Manish Doshi Director 17 Mar 2017 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 03 Apr 2017 Past
Pramod Abcsdd Director 26 Feb 2025 Past
Pramod Abcsdd Additional Director 29 Sep 2018 Past
Pramod Abcsdd Additional Director 29 Sep 2017 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Umedica Laboratories.

Umedica Laboratories Private Limited, for the financial year ended 2024, experienced Minor drop in revenue, with a 1.46% decrease. The company also saw a substantial improvement in profitability, with a 148.35% increase in profit. The company's net worth moved up by a moderate rise of 6.66%.

Umedica Laboratories revenue growth over time
Umedica Laboratories profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -1.46%
*******
*******
*******
*******
Revenue from Operations
*******
 -1.68%
*******
*******
*******
*******
Total Assets
*******
 -1.53%
*******
*******
*******
*******
Profit or Loss
*******
 148.35%
*******
*******
*******
*******
Net Worth
*******
 6.66%
*******
*******
*******
*******
EBITDA
*******
 42.49%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Umedica Laboratories?

In 2024, Umedica Laboratories had a promoter holding of 88.79% and a public holding of 11.21%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹5,318,600,000.00

Satisfied Charges

₹1,888,071,000.00

Charges Breakdown by Lending Institutions
  • Sbicap Trustee Company Limited : 427.16 Cr
  • Hdfc Bank Limited : 63.70 Cr
  • State Bank Of India : 30.00 Cr
  • Others : 9.00 Cr
  • Dbs Bank Ltd : 2.00 Cr
Latest Charge Details
Date Lender Amount Status
28 Jun 2022 Hdfc Bank Limited ₹15.00 Cr Open
10 Feb 2022 State Bank Of India ₹30.00 Cr Open
01 Nov 2021 Sbicap Trustee Company Limited ₹77.89 Cr Open
28 Oct 2021 Sbicap Trustee Company Limited ₹216.58 Cr Open
28 Oct 2021 Sbicap Trustee Company Limited ₹132.69 Cr Open

Explore comprehensive loan charge details -

How Many Employees Work at Umedica Laboratories?

Umedica Laboratories has a workforce of 869 employees as of Jan 17, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Umedica Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Umedica Laboratories's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Umedica Laboratories
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Umedica Laboratories Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.

  • Charges

    Progress on A charge registered on 18 May 2020 via Charge ID 100346851 with Others was fully satisfied on 20 Jun 2025. was documented.

  • Charges

    Progress on A charge registered on 14 May 2019 via Charge ID 100261751 with Others was fully satisfied on 02 Apr 2025. was documented.

  • Director Appointment

    The activity Heenal Pankaj Shah was appointed as a Company Secretary was appointed as a Company Secretary on 30 Jan 2025 & has been associated with this company since 1 year 3 months . was completed.

  • Balance Sheet

    Umedica Laboratories Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ahmedabad. was recorded as a recent event.

  • Charges

    A charge with Sbicap Trustee Company Limited of Rs. 132.69 Cr registered on 28 Oct 2021 with Charge ID 100497172 was modified on 23 Mar 2023. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Umedica Laboratories Private Limited?

The CIN of Umedica Laboratories Private Limited is U24231GJ1982PTC141202.

Where is Umedica Laboratories Private Limited headquartered?

Umedica Laboratories Private Limited is headquartered at P. No-221,222/1, Gidc, Vapi, Pardi, Gujarat, 396191.

When was Umedica Laboratories Private Limited incorporated?

Umedica Laboratories Private Limited was incorporated on 05 January 1982.

Who are the current directors of Umedica Laboratories Private Limited?

The current directors of Umedica Laboratories Private Limited are

What is the primary industry of Umedica Laboratories Private Limited?

The primary industry of Umedica Laboratories Private Limited is Manufacturing.

Is Umedica Laboratories Private Limited a listed company?

Umedica Laboratories Private Limited is unlisted.

What is the capital structure of Umedica Laboratories Private Limited?

The authorized capital of Umedica Laboratories Private Limited is ₹17.50 Cr, and the paid-up capital is ₹3.60 Cr.

What is the compliance status of Umedica Laboratories Private Limited?

The compliance status of Umedica Laboratories Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available